Gynecomastia and hypertension in a patient treated with posaconazole

George R. Thompson; Prasanth N Surampudi; Alex Odermatt

doi:10.1002/ccr3.3376

Gynecomastia and hypertension in a patient treated with posaconazole

George R. Thompson, Prasanth N Surampudi, Alex Odermatt

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Posaconazole therapy may lead to increased serum estradiol levels and development of gynecomastia. Early detection by endocrine hormone measurements may help preventing gynecomastia.

Original language	English (US)
Journal	Clinical Case Reports
DOIs	https://doi.org/10.1002/ccr3.3376
State	Accepted/In press - 2020

Keywords

11beta-hydroxylase
adverse drug effect
estradiol
gynecomastia
hypertension
hypokalemia
posaconazole

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1002/ccr3.3376

Fingerprint Dive into the research topics of 'Gynecomastia and hypertension in a patient treated with posaconazole'. Together they form a unique fingerprint.

Cite this

@article{504ad988130f49adb1b1522ecf94e7f9,

title = "Gynecomastia and hypertension in a patient treated with posaconazole",

abstract = "Posaconazole therapy may lead to increased serum estradiol levels and development of gynecomastia. Early detection by endocrine hormone measurements may help preventing gynecomastia.",

keywords = "11beta-hydroxylase, adverse drug effect, estradiol, gynecomastia, hypertension, hypokalemia, posaconazole",

author = "Thompson, {George R.} and Surampudi, {Prasanth N} and Alex Odermatt",

year = "2020",

doi = "10.1002/ccr3.3376",

language = "English (US)",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Gynecomastia and hypertension in a patient treated with posaconazole

AU - Thompson, George R.

AU - Surampudi, Prasanth N

AU - Odermatt, Alex

PY - 2020

Y1 - 2020

N2 - Posaconazole therapy may lead to increased serum estradiol levels and development of gynecomastia. Early detection by endocrine hormone measurements may help preventing gynecomastia.

AB - Posaconazole therapy may lead to increased serum estradiol levels and development of gynecomastia. Early detection by endocrine hormone measurements may help preventing gynecomastia.

KW - 11beta-hydroxylase

KW - adverse drug effect

KW - estradiol

KW - gynecomastia

KW - hypertension

KW - hypokalemia

KW - posaconazole

UR - http://www.scopus.com/inward/record.url?scp=85091614926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091614926&partnerID=8YFLogxK

U2 - 10.1002/ccr3.3376

DO - 10.1002/ccr3.3376

M3 - Article

AN - SCOPUS:85091614926

JO - Clinical Case Reports

JF - Clinical Case Reports

SN - 2050-0904

ER -

Gynecomastia and hypertension in a patient treated with posaconazole

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this